Nebraska Medicine, is a private not-for-profit American healthcare company based in Omaha, Nebraska. The company was created as Nebraska Health System in 1997, when Bishop Clarkson Hospital merged with the adjacent University Hospital in midtown Omaha.

During the past decade, Nebraska Medical Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 27 clinical trials were completed, i.e. on average, 108% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 18 clinical trials were completed. i.e. 360% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nebraska Medical Center" #1 sponsor was "University of Nebraska" with 17 trials, followed by "Radiation Therapy Oncology Group" with 13 trials sponsored, "United Therapeutics" with 5 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nebraska Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Nebraska Medical Center" are "Pulmonary Arterial Hypertension" (4 trials), "Cognitive/Functional Effects" (3 trials), "Cystic Fibrosis" (3 trials), "Head and Neck Cancer" (3 trials) and "Metastatic Cancer" (3 trials). Many other conditions were trialed in "Nebraska Medical Center" in a lesser frequency.

Most popular intervention types in "Nebraska Medical Center" are "Drug" (46 trials), "Device" (15 trials), "Radiation" (13 trials), "Other" (11 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "intensity-modulated radiation therapy" (4 trials), "IVA" (3 trials), "Ralinepag" (2 trials) and "SCV-07" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nebraska Medical Center" are 75 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Nebraska Medical Center". undefined are not yet recruiting, 7 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 43 completed trials in Nebraska Medical Center, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Nebraska Medical Center, 7 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 15 trials that are defined as “Not Applicable".